FR2609397A1 - Use of a substance or composition of carbohydrate nature as active principle of a dermatological and/or cosmetological and/or pharmaceutical and/or cell-stimulating composition, and composition containing such a substance or composition of carbohydrate nature - Google Patents
Use of a substance or composition of carbohydrate nature as active principle of a dermatological and/or cosmetological and/or pharmaceutical and/or cell-stimulating composition, and composition containing such a substance or composition of carbohydrate nature Download PDFInfo
- Publication number
- FR2609397A1 FR2609397A1 FR8802162A FR8802162A FR2609397A1 FR 2609397 A1 FR2609397 A1 FR 2609397A1 FR 8802162 A FR8802162 A FR 8802162A FR 8802162 A FR8802162 A FR 8802162A FR 2609397 A1 FR2609397 A1 FR 2609397A1
- Authority
- FR
- France
- Prior art keywords
- composition
- substance
- carbohydrate
- chosen
- nature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
Utilisation d'une substance ou composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmétologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique.Use of a substance or composition of a carbohydrate nature as active principle of a dermatological and / or cosmetological and / or pharmaceutical and / or cellular stimulant composition, and composition containing such a substance or composition of a carbohydrate nature.
La présente invention concerne essentiellement une utilisation d'une substance, et une composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmétologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique. The present invention essentially relates to a use of a substance, and a composition of a carbohydrate nature as an active principle of a dermatological and / or cosmetic and / or pharmaceutical and / or cellular stimulant composition, and composition containing such a substance or composition of carbohydrate.
Plus particulièrement, l'invention concerne l'utilisation d'une substance ou composition de nature glucidique d'origine naturelle, animale, végétale, micro-organique (bactéries, levures, fungi), extractive ou biotechnologique ou d'origine biosynthétique, comme principe actif d'une composition dermatologique et/ou cosmétologique et/ou pharmaceutique et/ou protectrice ou et/ou structurante et/ou bioénergisante ou accroissante des réserves énergétiques cellulaires, des membranes cellulaires, tissulaires. More particularly, the invention relates to the use of a substance or composition of a carbohydrate nature of natural, animal, plant, micro-organic (bacteria, yeast, fungi), extractive or biotechnological or of biosynthetic origin, as principle. active ingredient of a dermatological and / or cosmetic and / or pharmaceutical and / or protective or and / or structuring and / or bioenergizing or increasing energetic reserve of cellular, cellular, tissue membranes composition.
Selon un mode de réalisation avantageux de l'invention, cette substance ou composition de nature glucidique est présente seule ou en combinaison avec d'autres substances de nature glucidique ou en combinaison avec d'autres principes actifs, notamment de nature protidique, oligo- ou poly-peptidique, aminoacide ou lipidique, cette association permettant ainsi d'améliorer et/ou de compléter leur activité précitée. According to an advantageous embodiment of the invention, this substance or composition of carbohydrate nature is present alone or in combination with other substances of carbohydrate nature or in combination with other active principles, in particular of protein, oligo- or poly-peptide, amino acid or lipid, this association thus making it possible to improve and / or supplement their abovementioned activity.
Selon un mode de réalisation particulier, cette substance ou composition de nature glucidique est incorporée dans des vésicules de type liposomes ou dans des phases lamellaires lipidiques hydratées. According to a particular embodiment, this substance or composition of a carbohydrate nature is incorporated in vesicles of the liposome type or in hydrated lipid lamellar phases.
Cette substance de type glucidique est, selon un mode de réalisation préféré, choisie parmi les structures osiques, osidiques et hétérosidiques. This carbohydrate type substance is, according to a preferred embodiment, chosen from osic, osidic and heterosidic structures.
Les oses peuvent être définis comme suit o OSES
- Aldoses, notamment choisis parmi le groupe comprenant
D-Glycéraldéhyde, Thréose, Erythrose, Lyxose, Xylose,
Arabinose, Ribose, Talose, Galactose, Idose, Gulose,
Mannose, Glucose, Altrose, Allose
- Cétoses, notamment choisis parmi le groupe comprenant
Dihydroxyacétone, Erythrulose, Xylulose, Ribulose,
Ribose, Tagatose, Sorbose, Fructose, Allulose, ainsi
que leur homologue désoxy tels que désoxyribose
- Glucosamine, Acétylglucosamine.The dares can be defined as follows o OSES
- Aldoses, in particular chosen from the group comprising
D-Glyceraldehyde, Threose, Erythrose, Lyxose, Xylose,
Arabinose, Ribose, Talose, Galactose, Idose, Gulose,
Mannose, Glucose, Altrose, Allose
- Ketoses, in particular chosen from the group comprising
Dihydroxyacetone, Erythrulose, Xylulose, Ribulose,
Ribose, Tagatose, Sorbose, Fructose, Allulose, as well
that their deoxy counterpart such as deoxyribose
- Glucosamine, Acetylglucosamine.
-Acides uroniques, notamment choisis parmi le groupe
comprenant l'acide D-glucuronique, D-galacturonique,
D-mannuronique
- Oses complexes, notamment choisis parmi le groupe com
prenant l'acide cétodésoxyoctulosonique, l'acide mura
mique, neuraminique.-Uronic acids, especially chosen from the group
including D-glucuronic acid, D-galacturonic,
D-mannuronic
- Complex bones, in particular chosen from the com group
taking ketodeoxyoctulosonic acid, mura acid
mique, neuramine.
Les osides sont avantageusement choisis parmi
- Les diholosides
Réducteurs comme le lactose, le maltose, le cello
biose, le gentiobiose, le mélibiose,
non réducteurs, tels que le saccharose, le tréhalose
- Les triholosides, tels que le gentianose, le raffi
nose, le mélézitose
- Les polyosides
Ce pourra etre
un homopolyholoside, végétal animal ou micro
organique (bactéries, levures, fungi)
Glucanes (amidon, glycogène, cellulose)
Galactanes (sulfatés/agar-agar, carragénine, ou
non sulfatés)
Mannanes (mucilages)
Fructosanes (inuline)
Arabanes
Xylanes
et leurs dérivés tels que la Chitine, les Chitosans
un hétéropolyholoside
Galactomannane
Hémicellulose
Gommes et mucilages
. un polyuronide
Pectine végétale ou bactérienne
Acide alginique
Gomme arabique
. les mucopolysaccharides acides tels que la
chrondroitine sulfate, le dermatane sulfate,
utilisés libres ou associés à une partie polypepti
dique sous forme de protéoglycannes acides, les kéra
tane-sulfates, l'acide hyaluronique
Acide téichoique.The osides are advantageously chosen from
- Diholosides
Reducers like lactose, maltose, cello
biosis, gentiobiosis, melibiose,
non-reducing, such as sucrose, trehalose
- Triholosides, such as gentianose, raffi
nose, melezitosis
- Polysaccharides
It could be
a homopolyholoside, animal or micro plant
organic (bacteria, yeast, fungi)
Glucans (starch, glycogen, cellulose)
Galactans (sulfates / agar-agar, carrageenan, or
not sulfated)
Mannans (mucilages)
Fructosanes (inulin)
Arabanes
Xylanes
and their derivatives such as Chitin, Chitosans
a heteropolyholoside
Galactomannan
Hemicellulose
Erasers and mucilages
. a polyuronide
Vegetable or bacterial pectin
Alginic acid
Gum arabic
. acid mucopolysaccharides such as
chrondroitin sulfate, dermatan sulfate,
used free or associated with a polypepti part
dique in the form of acid proteoglycans, kera
tane sulfates, hyaluronic acid
Teichoic acid.
Les hétérosides seront avantageusement choisis parmi
. Hétérosides anthraquinoniques
. Hétérosides hétérocycliques oxygénés coumariniques,
flavoniques, anthocyaniques (famille des Composées)
. les tanins
. les saponosides, en particulier des Liliacées,
Caryophyllacées,
. les conjugués, glucoroniques
les glycolipides
Ces substances glucidiques ou glucides pourront être utilisées seules ou en combinaison et incorporées dans des préparations de type crème, gel, lotion, lait, baume pour former des compositions dermatologiques et/ou cosmétologiques et/ou pharmaceutiques à visée renforçatrice du potentiel bioénergétique cellulaire ou tissulaire à visée, structuratrice, ou à visée ou tissulaire.The heterosides will advantageously be chosen from
. Anthraquinone heterosides
. Coumarinated heterocyclic oxygen heterosides,
flavonics, anthocyanins (family of Compounds)
. tannins
. saponosides, in particular Liliaceae,
Caryophyllaceae,
. conjugates, glucoronic
glycolipids
These carbohydrate or carbohydrate substances may be used alone or in combination and incorporated into preparations of the cream, gel, lotion, milk or balm type to form dermatological and / or cosmetological and / or pharmaceutical compositions for reinforcing the bioenergetic cell or tissue potential. aiming, structuring, or aiming or tissue.
Ces compositions pourront agir dans le sens d'une amélioration du confort cutané, grâce à leur effet hydratant, adoucissant, assouplissant, énergisant. These compositions can act in the direction of improving skin comfort, thanks to their hydrating, softening, softening and energizing effect.
Une autre activité présentée par ces glucides consiste en une action ' astringente, hémostatique, tonifiante veineuse, une action anti-inflammatoire, protectrice cellulaire ou tissulaire. Another activity presented by these carbohydrates consists of an astringent, haemostatic, venous toning action, an anti-inflammatory action, protective cell or tissue.
L'utilisation d'oses simples ou de polyosides leur confère une action plus spécifiquement hydratante, nourrissante. The use of simple oses or polysaccharides gives them a more specifically hydrating, nourishing action.
On peut leur adjoindre des mucilages pour leur donner une action adoucissante. We can add mucilage to them to give them a softening action.
Par ailleurs, l'utilisation de glucosides végétaux est particulièrement intéressante en leur conférant une action antiinflammatoire, astringente, cicatrisante, tonifiante veineuse ou photoprotectrice. Les glucosides végétaux sont avantageusement choisis parmi les tanins des Conifères, des Cupulifères, des
Ericacées, des Labiées, des Légumineuses, des Myrtacées, des
Polygonacées, des Rosacées, des Rubiacées, des hétérosides divers, des flavonoides des Polygonacées, des Rutacées, des Légumineuses, des Ombellifères ou des Composées.In addition, the use of vegetable glucosides is particularly advantageous by conferring on them an anti-inflammatory, astringent, healing, venous or photoprotective action. The plant glucosides are advantageously chosen from the tannins of conifers, cupulifers,
Ericaceae, Labiatae, Legumes, Myrtaceae,
Polygonaceae, Rosaceae, Rubiaceae, various heterosides, flavonoids of Polygonaceae, Rutaceae, Legumes, Umbelliferae or Compositae.
Un couplage des différentes substances de type glucidique permet d'obtenir une action cosméto-dynamique supérieure. A coupling of the various carbohydrate-type substances makes it possible to obtain a superior cosmetic-dynamic action.
La présente invention couvre également une composition notamment dermatologique et/ou cosmétologique et/ou pharmaceutique et/ou protectrice cellulaire, caractérisée en ce qu'elle contient au moins une substance ou composition de nature glucidique telle que ci-dessus définie. La proportion de la substance de nature glucidique est de préférence de 0,01 à 20 % en poids par rapport au poids total de la composition. The present invention also covers a composition, in particular a dermatological and / or cosmetic and / or pharmaceutical and / or cellular protective composition, characterized in that it contains at least one substance or composition of carbohydrate nature as defined above. The proportion of the substance of a carbohydrate nature is preferably from 0.01 to 20% by weight relative to the total weight of the composition.
Selon un mode de réalisation particulièrement intéressant, la substance de nature glucidique'précitée est incorporée dans des vésicules de type liposomes ou dans des phases lamellaires lipidiques hydratées, notamment à une proportion sensiblement égale en poids des vésicules ou des phases lamellaires lipidiques par rapport à la phase aqueuse. Cette composition peut être sous forme de crème, de gel, de lotion. According to a particularly advantageous embodiment, the substance of the above-mentioned carbohydrate nature is incorporated in vesicles of the liposome type or in hydrated lipid lamellar phases, in particular at a proportion substantially equal by weight of the vesicles or lipid lamellar phases relative to the aqueous phase. This composition can be in the form of a cream, gel, lotion.
Une combinaison particulièrement intéressante de glucides est la combinaison saccharose, dextrose, fructose. A particularly interesting combination of carbohydrates is the combination of sucrose, dextrose, fructose.
D'autres buts, caractéristiques et avantages déterminants de l'invention apparaitront clairement à la lumiere de la description explicative qui va suivre faite en référence à divers exemples de compositions dermatologiques et/ou cosmétologiques et/ou pharmaceutiques et/ou protectrice cellulaire, données simplement à titre d'illustration et qui ne sauraient donc en aucune façon limiter la portée de l'invention. Dans les exemples, tous les pourcentages sont donnés en poids, sauf indication contraire. Other goals, characteristics and decisive advantages of the invention will appear clearly in the light of the explanatory description which will follow made with reference to various examples of dermatological and / or cosmetological and / or pharmaceutical and / or cellular protective compositions, given simply by way of illustration and which therefore cannot in any way limit the scope of the invention. In the examples, all the percentages are given by weight, unless otherwise indicated.
Dans chaque cas, les phases A et B, préalablement chauffées à environ 800C, sont mélangées et émulsionnées puis refroidies. In each case, phases A and B, previously heated to around 800C, are mixed and emulsified and then cooled.
Enfin, s'il y a lieu les phases restantes sont ajoutées. Finally, if necessary, the remaining phases are added.
EXEMPLE 1 : Crème à visée hydratante et nourrissante
Phase A : PROPYLENE GLYCOL 5,00
PEG-100 3,00
SACCHAROSE 2,00
DEXTROSE 1,00
FRUCTOSE 2,50
CHONDROITINE SULFATE 0,50
METHYLPARABEN 0,50
EAU DISTILLEE 66,50
Phase B : HUILE de PARAFFINE 11,00
GLYCERYL STEARATE 5,00
LANOLINE LIQUIDE 3,00
Le mélange de ces constituants se fait de la manière habituelle.EXAMPLE 1 Cream with Hydrating and Nourishing Aim
Phase A: PROPYLENE GLYCOL 5.00
PEG-100 3.00
SACCHAROSE 2.00
DEXTROSE 1.00
FRUCTOSE 2.50
CHONDROITINE SULFATE 0.50
METHYLPARABEN 0.50
DISTILLED WATER 66.50
Phase B: PARAFFIN OIL 11.00
GLYCERYL STEARATE 5.00
LIOLID LANOLIN 3.00
The mixing of these constituents is carried out in the usual manner.
EXEMPLE 2 : Gel pour le visage
Phase A : GLYCOGENE 0,15
MANNITOL 0,50
EXTRAIT de COMPOSEES 1,00
SORBITOL 0,30
CONSERVATEUR 0,20
EAU DISTILLEE 82,35
GLYCERINE 2,00
* PEG 1500 8,00
Phase B : CARPOBOL R 5,00
TRIETHANOLAMINE 0,50 * PEG = Polyéthylèneglycol
De manière classique, sous agitation, on ajoute tous les composants dans l'eau (à l'exception du carbopoR puis on ajoute le carbopolR pour R pour gélifier la solution.EXAMPLE 2 Face gel
Phase A: GLYCOGENE 0.15
MANNITOL 0.50
COMPOUND EXTRACT 1.00
SORBITOL 0.30
CONSERVATIVE 0.20
DISTILLED WATER 82.35
GLYCERINE 2.00
* PEG 1500 8.00
Phase B: CARPOBOL R 5.00
TRIETHANOLAMINE 0.50 * PEG = Polyethylene glycol
Conventionally, with stirring, all the components are added in water (with the exception of carbopoR and then carbopolR for R is added to gel the solution.
EXEMPLE 3 : Lotion apaisante
Phase A : EXTRAITS de COMPOSEES 2,50
EXTRAIT de LABIEES 1,00
EXTRAIT de ROSACEES 1,00
GOMME GUAR 1,00
METHYLPARABEN 0,30
GLYCERINE 2,50
EAU DISTILLEE 91,55
Phase C : PARFUM 0,15
EXEMPLE 4 : Crème nourrissante
Phase A : SACCHAROSE 2,50
DEXTROSE 1,80
FRUCTOSE 0,80
CHRONDROITINE SULFATE 0,01
METHYLPARABEN 0,20
EAU DISTILLEE 69,34
Phase B : CHOLESTEROL 0,50
TWEEN 60 1,50
MYRISTATE d'ISOPROPYLE 5,00
SPAN 40 2,20
VASELINE 6,00
LANOLINE 10,00
Phase C : PARFUM 0,15
EXEMPLE 5 : Crème hydratante
Phase A : GLYCOGENE 0,05
MANNITOL 0,20
METHYLPARABEN 0,10
PROPYLENE GLYCOL 2,50
EAU DISTILLEE 69,50
PEG 100 5,00
Phase B : CHOLESTEROL 0,50
STEARATE de GLYCEROL AE 5,00
HUILE de VASELINE 2,00
MYRISTATE d'ISOPROPYLE 15,00
Phase C :PARFUM 0,15
On pourra leur associer d'autres principes actifs, de nature protidique, polypeptidique, oligopeptidique, ou amino-acide à des doses de 0,01 à 50 %, ce qui complétera leur activité cosméto dynamique.EXAMPLE 3 Soothing Lotion
Phase A: EXTRACTS OF COMPOUNDS 2.50
LABIE EXTRACT 1.00
EXTRACT OF ROSACEOUS 1.00
GUAR GUM 1.00
METHYLPARABEN 0.30
GLYCERINE 2.50
DISTILLED WATER 91.55
Phase C: PERFUME 0.15
EXAMPLE 4 Nourishing Cream
Phase A: SACCHAROSE 2.50
DEXTROSE 1.80
FRUCTOSE 0.80
CHRONDROITINE SULFATE 0.01
METHYLPARABEN 0.20
DISTILLED WATER 69.34
Phase B: CHOLESTEROL 0.50
TWEEN 60 1.50
ISOPROPYLE MYRISTATE 5.00
SPAN 40 2.20
VASELINE 6.00
LANOLINE 10.00
Phase C: PERFUME 0.15
EXAMPLE 5 Hydrating cream
Phase A: GLYCOGENE 0.05
MANNITOL 0.20
METHYLPARABEN 0.10
PROPYLENE GLYCOL 2.50
DISTILLED WATER 69.50
PEG 100 5.00
Phase B: CHOLESTEROL 0.50
GLYCEROL AE STEARATE 5.00
VASELIN OIL 2.00
ISOPROPYLE MYRISTATE 15.00
Phase C: PERFUME 0.15
We can associate them with other active principles, of a protein, polypeptide, oligopeptide or amino acid nature in doses of 0.01 to 50%, which will complete their cosmetic dynamic activity.
Par exemple, dans le domaine de la cicatrisation, l'adjonction de facteurs nutritifs aura un effet bénéfique. For example, in the area of wound healing, the addition of nutritional factors will have a beneficial effect.
EXEMPLE 6 : Crème régénératrice
Phase A : COLLAGENE 5,00
GLUCOSE 5,00
ADN 0,20
L-LYSINE 0,10
L-ALANINE 2,55
GALACTOSE 1,50
METHYLPARABEN 0,15
EAU DISTILLEE 47,85
Phase B : BRIJ 58 2,00
(polyéthylène glycol cetyléther)
HUILE de PARAFFINE 5,00
GLYCERINE 10,00
SPAN 60 2,50
PEG STEARATE 5,00
MIGLYOL 892 8,00
VASELINE 5,00
Phase C : PARFUM 0,15
EXEMPLE 7 : Crème hydratante, nourrissante, antiinflammatoire
Phase A : D-GLUCOSAMINE 0,25
ACIDE GLUTAMIQUE 0,10
D-GLUCOSE 1,00
GLYCOGENE 1,50
EXTRAIT de RUTACEES 1,00
METHYLPARABEN 0,20
EAU DISTILLEE 64,30
Phase B : CIRE de CARNAUBA 3,50
LANOLINE 15,00
MYRISTATE d'ISOPROPYLE 10,00
ARLACEL C 3,00
Phase C : PARFUM 0,15
EXEMPLE 8 : Creme adoucissante
Phase A :L-LYSINE 0,30
L-CYSTEINE 0,25
EXTRAIT de COMPOSEES 2,00
METHYLPARABEN 0,30
GOMME ADRAGANTE 1,00
PECTINE 2,00
EAU DISTILLEE 74,95
PROPYLENE GLYCOL 5,00
Phase B : HUILE de PARAFFINE 10,00
STEARATE de GLYCEROL A.E. 2,00
LANOLINE LIQUIDE 2,00
Phase C : PARFUM 0,20
EXEMPLE 9 : Gel réparateur
Phase A : ACIDE HYALURONIQUE 0,50
N-ACETYL GLUCOSAMINE 1,00
MUCILAGE 1,00
CHONDROITINE SULFATE 0,50
COLLAGENE 1,00
ELASTINE 0,50
METHYLPARABEN 0,30
EAU DISTILLEE 84,00
Phase C : CARBOPOL 10,zoo
TRIETHANOLAMINE 1,00
Phase D : PARFUM 0,20
EXEMPLE 10 : Crème hydratante
Phase A : SACCHAROSE 2,00
DEXTROSE 3,00
OH-PROLINE 0,50
L-ALANINE 0,50
PROPYLENE GLYCOL 2,50
METHYLPARABEN 0,20
EAU DISTILLEE 62,15
Phase B : CIRE de CARNAUBA 2,00
MYRISTATE d'ISOPROPYLE 25,00
HUILE de PARAFFINE 2,00
Phase C :PARFUM 0,15
Ces principes actifs utilisés, seuls ou en combinaison, pourront être présentés de façon avantageuse sous forme liposomée, selon la technique suivante
Les principes actifs sont préparés sous forme d'une solution aqueuse. La membrane des liposomes sera constituée de
- phospholipides, d'origine naturelle ou synthétique
- phospholipides associés à des glycérides
- cholestérol, naturel
-'phospholipides associés à des glycolipides
- lipoprotéines associées à des . cérébrosides
. sphinogolipides
. céphalines
. phospho-amino-lipides
. cérébroglucosides
gangliosides
Ces deux composants sont tout d'abord dissous dans un solvant volatile, variant selon le type de phospholipides choisis, par exemple le chloroforme, le méthanol.EXAMPLE 6 Regenerating Cream
Phase A: COLLAGENE 5.00
GLUCOSE 5.00
DNA 0.20
L-LYSINE 0.10
L-ALANINE 2.55
GALACTOSE 1.50
METHYLPARABEN 0.15
DISTILLED WATER 47.85
Phase B: BRIJ 58 2.00
(polyethylene glycol cetyl ether)
PARAFFIN OIL 5.00
GLYCERINE 10.00
SPAN 60 2.50
PEG STEARATE 5.00
MIGLYOL 892 8.00
VASELINE 5.00
Phase C: PERFUME 0.15
EXAMPLE 7 Hydrating, nourishing, anti-inflammatory cream
Phase A: D-GLUCOSAMINE 0.25
GLUTAMIC ACID 0.10
D-GLUCOSE 1.00
GLYCOGENE 1.50
EXTRACT OF RUTACEES 1.00
METHYLPARABEN 0.20
DISTILLED WATER 64.30
Phase B: CARNAUBA WAX 3.50
LANOLINE 15.00
ISOPROPYLE MYRISTATE 10.00
ARLACEL C 3.00
Phase C: PERFUME 0.15
EXAMPLE 8 Softening cream
Phase A: L-LYSINE 0.30
L-CYSTEINE 0.25
COMPOUND EXTRACT 2.00
METHYLPARABEN 0.30
ADRAGANANT ERASER 1.00
PECTIN 2,00
DISTILLED WATER 74.95
PROPYLENE GLYCOL 5.00
Phase B: PARAFFIN OIL 10.00
GLARCEROL AE STEARATE 2.00
LIOLID LANOLIN 2.00
Phase C: PERFUME 0.20
EXAMPLE 9 Repairing gel
Phase A: HYALURONIC ACID 0.50
N-ACETYL GLUCOSAMINE 1.00
MUCILAGE 1.00
CHONDROITINE SULFATE 0.50
COLLAGEN 1.00
ELASTINE 0.50
METHYLPARABEN 0.30
DISTILLED WATER 84.00
Phase C: CARBOPOL 10, zoo
TRIETHANOLAMINE 1.00
Phase D: PERFUME 0.20
EXAMPLE 10 Hydrating Cream
Phase A: SUCROSE 2.00
DEXTROSE 3.00
OH-PROLINE 0.50
L-ALANINE 0.50
PROPYLENE GLYCOL 2.50
METHYLPARABEN 0.20
DISTILLED WATER 62.15
Phase B: CARNAUBA WAX 2.00
ISOPROPYLE MYRISTATE 25.00
PARAFFIN OIL 2.00
Phase C: PERFUME 0.15
These active ingredients used, alone or in combination, can be advantageously presented in liposomal form, according to the following technique
The active ingredients are prepared in the form of an aqueous solution. The liposome membrane will consist of
- phospholipids, of natural or synthetic origin
- phospholipids associated with glycerides
- cholesterol, natural
-'phospholipids associated with glycolipids
- lipoproteins associated with. cerebrosides
. sphinogolipids
. cephalins
. phospho-amino lipids
. cerebroglucosides
gangliosides
These two components are first dissolved in a volatile solvent, varying according to the type of phospholipids chosen, for example chloroform, methanol.
Le mélange est placé dans un ballon puis évaporé sous pression réduite dans un évaporateur rotatif, jusqu'à formation d'un film sur les parois du ballon. The mixture is placed in a flask and then evaporated under reduced pressure in a rotary evaporator, until a film is formed on the walls of the flask.
Puis, on ajoute, sous agitation constante, la solution aqueuse de principes actifs à encapsuler. Then, with constant stirring, the aqueous solution of active ingredients to be encapsulated is added.
La suspension obtenue est fractionnée aux ultra-sons sous forme de microglobules ou microsphérules. The suspension obtained is fractionated with ultrasound in the form of microglobules or microspherules.
On obtient ainsi une suspension de liposomes actifs. A suspension of active liposomes is thus obtained.
L'encapsulation des actifs entraîne une optimisation de leur activité cosméto dynamique. The encapsulation of the active ingredients leads to an optimization of their cosmetic-dynamic activity.
EXEMPLE 11
- Phase phospholipidique
PHOSPHOLIPIDES 90,00
CHOLESTEROL 10,00
- Phase aqueuse active
SACCHAROSE 2,50
DEXTROSE 1,80
FRUCTOSE 0,80
CHONDROITINE SULFATE 0,01
METHYLPARABEN 0,20
EAU DISTILLEE qsp 100,00
La préparation se fera selon la technique ci-dessus décrite.EXAMPLE 11
- Phospholipid phase
PHOSPHOLIPIDS 90.00
CHOLESTEROL 10.00
- Active aqueous phase
SACCHAROSE 2.50
DEXTROSE 1.80
FRUCTOSE 0.80
CHONDROITINE SULFATE 0.01
METHYLPARABEN 0.20
DISTILLED WATER qs 100.00
The preparation will be done according to the technique described above.
EXEMPLE 12
- Phase phospholipidique
PHOSPHOLIPIDES 90,00
CHOLESTEROL 10,00
- Phase aqueuse active
GLYCOGENE 6,00
MANNITOL 5,00
METHYLPARABEN 0,20
EAU DISTILLEE qsp 100,00
La préparation se fera selon la technique ci-dessus decrite.EXAMPLE 12
- Phospholipid phase
PHOSPHOLIPIDS 90.00
CHOLESTEROL 10.00
- Active aqueous phase
GLYCOGENE 6.00
MANNITOL 5.00
METHYLPARABEN 0.20
DISTILLED WATER qs 100.00
The preparation will be done according to the technique described above.
EXEMPLE 13
- Phase phospholipidique
PHOSPHOLIPIDES 90,00
CHOLESTEROL 10,00
- Phase aqueuse active
SACCHAROSE 2,00
DEXTROSE 3,00
OH-PROLINE 0,50
L-ALANINE 0,50
METHYLPARABEN 0,20
EAU DISTILLEE qsp 100,00
La préparation se fera selon la technique ci-dessus exposée. EXAMPLE 13
- Phospholipid phase
PHOSPHOLIPIDS 90.00
CHOLESTEROL 10.00
- Active aqueous phase
SACCHAROSE 2.00
DEXTROSE 3.00
OH-PROLINE 0.50
L-ALANINE 0.50
METHYLPARABEN 0.20
DISTILLED WATER qs 100.00
The preparation will be done according to the technique described above.
EXEMPLE 14
- Phase lipidique
GLYCOSPHINGOLIPIDES 100
- Phase aqueuse active
D-GLUCOSAMINE 0,25
L-ARGININE CHLORHYDRATE 0,10
D-GLUCOSE 1,00
GLYCOGENE 1,50
EXTRAIT de RUTACEES + CARYOPHYLACEES 1,00
METHYLPARABEN 0,20
EAU DISTILLEE qsp 100,00 même préparation qu'aux exemples 11 à 13.EXAMPLE 14
- Lipid phase
GLYCOSPHINGOLIPIDS 100
- Active aqueous phase
D-GLUCOSAMINE 0.25
L-ARGININE HYDROCHLORIDE 0.10
D-GLUCOSE 1.00
GLYCOGENE 1.50
EXTRACT OF RUTACEOUS + CARYOPHYLACEOUS 1.00
METHYLPARABEN 0.20
DISTILLED WATER qs 100.00 same preparation as in examples 11 to 13.
EXEMPLE 15
- Phase phospholipidique
PHOSPHOLIPIDES 90
CHOLESTEROL 10
- Phase aqueuse active
COLLAGENE 5,00
GLUCOSE 5,00
ADN 0,10
L-ALANINE 0,10
GALACTOSE 1,50
METHYLPARABEN 0,20
EAU DISTILLEE qsp 100,00 même préparation qu'aux exemples 11 à 13. EXAMPLE 15
- Phospholipid phase
PHOSPHOLIPIDS 90
CHOLESTEROL 10
- Active aqueous phase
COLLAGEN 5.00
GLUCOSE 5.00
DNA 0.10
L-ALANINE 0.10
GALACTOSE 1.50
METHYLPARABEN 0.20
DISTILLED WATER qs 100.00 same preparation as in examples 11 to 13.
EXEMPLE 16
- Phase phospholipidique
PHOSPHOLIPIDES 90
CHOLESTEROL 10
- Phase aqueuse active
ACIDES AMINES PLASMATIQUES 1,00
SACCHAROSE 2,50
GOMME GUAR 1,00
EXTRAIT de LABIEES 1,00
EXTRAIT de ROSACEES 1,00
METHYLPARABEN 0,20
EAU DISTILLE qsp 100,00 même préparation qu'aux exemples 11 à 15.EXAMPLE 16
- Phospholipid phase
PHOSPHOLIPIDS 90
CHOLESTEROL 10
- Active aqueous phase
PLASMATIC AMINO ACIDS 1.00
SACCHAROSE 2.50
GUAR GUM 1.00
LABIE EXTRACT 1.00
EXTRACT OF ROSACEOUS 1.00
METHYLPARABEN 0.20
DISTILLED WATER qs 100.00 same preparation as in examples 11 to 15.
EXEMPLE 17
- Phase phospholipidique
PHOSPHOLIPIDES 90
CHOLESTEROL 10
- Phase aqueuse active
POLYPEPTIDES PLASMATIQUES 0,15
RIBOSE 0,50
EXTRAIT de COMPOSEES 1,00
SORBITOL 0,30
METHYLPARABEN 0,20
EAU DISTILLEE qsp 100,00 même préparation qu'aux exemples Il à 16. EXAMPLE 17
- Phospholipid phase
PHOSPHOLIPIDS 90
CHOLESTEROL 10
- Active aqueous phase
PLASMATIC POLYPEPTIDES 0.15
RIBOSE 0.50
COMPOUND EXTRACT 1.00
SORBITOL 0.30
METHYLPARABEN 0.20
DISTILLED WATER qs 100.00 same preparation as in examples II to 16.
EXEMPLE 18
- Phase phospholipidique
PHOSPHOLIPIDES 90
CHOLESTEROL 10
- Phase aqueuse active
FRUCTOSE 0,25
CHONDROITINE SULFATE 0,50
METHYLPARABEN 0,50
EAU DISTILLEE qsp 100,00 même préparation qu'aux exemples 11 à 17.EXAMPLE 18
- Phospholipid phase
PHOSPHOLIPIDS 90
CHOLESTEROL 10
- Active aqueous phase
FRUCTOSE 0.25
CHONDROITINE SULFATE 0.50
METHYLPARABEN 0.50
DISTILLED WATER qs 100.00 same preparation as in examples 11 to 17.
On peut constater des exemples qui précèdent 11 à 18 que, lorsque les principes actifs sont présents sous forme liposomée, ils pourront être incorporés dans diverses préparations cosmétiques du type gel, crème, lotion, dont la phase active est environ égale en poids à la phase phospholipidique. It can be seen from the examples above 11 to 18 that, when the active principles are present in liposomal form, they may be incorporated into various cosmetic preparations of the gel, cream, lotion type, the active phase of which is approximately equal in weight to the phase phospholipid.
Grâce à l'incorporation sous forme liposomée, on obtient une supériorité de l'activité que ce soit concernant l'activité hydratante, assouplissante, adoucissante, énergisante, anti-inflammatoire, cicatrisante, astringente, hémostatique, tonifiante veineuse, stimulante, protectrice cellulaire. Thanks to the incorporation in liposomal form, one obtains a superiority of the activity whether it is concerning the hydrating, softening, softening, energizing, anti-inflammatory, healing, astringent, hemostatic, venous toning, stimulating, cell protective activity.
Naturellement, l'invention comprend tous les moyens constituant des équivalents techniques des moyens décrits ainsi que leurs diverses combinaisons. Naturally, the invention includes all the means constituting technical equivalents of the means described as well as their various combinations.
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8802162A FR2609397B1 (en) | 1988-02-23 | 1988-02-23 | USE OF A CARBOHYDRATE SUBSTANCE OR COMPOSITION AS AN ACTIVE INGREDIENT OF A DERMATOLOGICAL AND / OR COSMETOLOGICAL AND / OR PHARMACEUTICAL AND / OR CELL STIMULANT COMPOSITION, AND COMPOSITION CONTAINING SUCH A CARBON SUBSTANCE OR COMPOSITION |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8802162A FR2609397B1 (en) | 1988-02-23 | 1988-02-23 | USE OF A CARBOHYDRATE SUBSTANCE OR COMPOSITION AS AN ACTIVE INGREDIENT OF A DERMATOLOGICAL AND / OR COSMETOLOGICAL AND / OR PHARMACEUTICAL AND / OR CELL STIMULANT COMPOSITION, AND COMPOSITION CONTAINING SUCH A CARBON SUBSTANCE OR COMPOSITION |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2609397A1 true FR2609397A1 (en) | 1988-07-15 |
FR2609397B1 FR2609397B1 (en) | 1991-12-13 |
Family
ID=9363520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8802162A Expired - Lifetime FR2609397B1 (en) | 1988-02-23 | 1988-02-23 | USE OF A CARBOHYDRATE SUBSTANCE OR COMPOSITION AS AN ACTIVE INGREDIENT OF A DERMATOLOGICAL AND / OR COSMETOLOGICAL AND / OR PHARMACEUTICAL AND / OR CELL STIMULANT COMPOSITION, AND COMPOSITION CONTAINING SUCH A CARBON SUBSTANCE OR COMPOSITION |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2609397B1 (en) |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2639828A1 (en) * | 1988-12-01 | 1990-06-08 | Lvmh Rech | USE OF KAEMPFEROL AND SOME DERIVATIVES THEREOF FOR THE PREPARATION OF A COSMETIC OR PHARMACEUTICAL COMPOSITION |
EP0382210A1 (en) * | 1989-02-08 | 1990-08-16 | Unitika Ltd. | The use of deacetylated chitin for preparing a medicament for the treatment of inflammatory skin diseases |
WO1990011069A1 (en) * | 1989-03-20 | 1990-10-04 | Parfums Christian Dior | Process for the preparation of a ligand-receptor complex |
FR2652742A1 (en) * | 1989-10-11 | 1991-04-12 | Vacher Dominique | Anallergic cosmetic and dermopharmaceutical compositions |
EP0432309A1 (en) * | 1989-12-15 | 1991-06-19 | Laevosan-Gesellschaft m.b.H. | Sugar derivatives, process for their preparation and their use |
EP0500718A1 (en) * | 1989-11-09 | 1992-09-02 | Byron A Donzis | Insoluble yeast extract. |
WO1992015311A1 (en) * | 1991-03-01 | 1992-09-17 | Depha Team S.R.L. | Dietetic or pharmaceutical compositions for the restoration of adenine nucleotide cell content in skeletal and cardiac muscles |
FR2683721A1 (en) * | 1991-11-15 | 1993-05-21 | Inocosm Laboratoires | POLAR LIPID COMPOSITION FOR VEHICULATING AN ACTIVE AGENT AND / OR PENETRATING IT INTO A TARGET CELL |
WO1994002586A2 (en) * | 1992-07-24 | 1994-02-03 | Agricultural And Food Research Council | Repression of virulent gene expression |
WO1995005155A1 (en) * | 1993-08-17 | 1995-02-23 | Roc S.A. | Use of oligosaccharides for the prevention and treatment of tissue ageing |
WO1996023479A2 (en) * | 1995-02-03 | 1996-08-08 | Beiersdorf Ag | Anti-adhesive active principles |
FR2730409A1 (en) * | 1995-02-15 | 1996-08-14 | Dior Christian Parfums | USE OF GALACTOLIPIDS, IN PARTICULAR GALACTOSYLGLYCERIDES, AND EXTRACTS OF NATURAL ORIGIN CONTAINING THESE PRODUCTS, IN THE COSMETIC, PHARMACEUTICAL AND IN PARTICULAR DERMATOLOGICAL FIELDS |
FR2743296A1 (en) * | 1996-01-10 | 1997-07-11 | Oreal | New cleansing or make-up removal composition |
EP0783883A3 (en) * | 1996-01-10 | 1997-08-13 | L'oreal | Use of polyholosides in cleaning compositions or in make-up removers, and compositions containing the same |
EP0693928A4 (en) * | 1993-03-31 | 1998-06-03 | Nutramax Lab Inc | Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
EP0852946A3 (en) * | 1996-11-29 | 1998-09-16 | Gianfranco De Paoli Ambrosi | Composition for cosmetic, pharmaceutical or dietetic use based on an amino-sugar and/or a polyhydroxylic acid |
EP0979090A1 (en) * | 1997-04-28 | 2000-02-16 | Nutramax Laboratories, Inc. | Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine |
WO2000054743A1 (en) * | 1999-03-12 | 2000-09-21 | Biotec Asa | Cosmetic and/or pharmaceutical preparations |
EP1075836A2 (en) * | 1999-08-09 | 2001-02-14 | Yaizu Suisankagaku Industry Co., Ltd. | Skin care of food composition containing N-acetyl-glucosamine |
US6271213B1 (en) | 1996-12-23 | 2001-08-07 | Nutramax Laboratories, Inc. | Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue |
WO2002076423A2 (en) * | 2001-03-22 | 2002-10-03 | The Procter & Gamble Company | Skin care compositions containing a sugar amine |
DE10126396A1 (en) * | 2001-05-31 | 2002-12-05 | Beiersdorf Ag | Cosmetic or dermatological preparations containing glucosamine, useful e.g. for treatment, care and prophylaxis of sensitive skin and treatment of inflammatory conditions such as eczema or psoriasis |
WO2003092703A1 (en) * | 2002-04-30 | 2003-11-13 | Hisamitsu Pharmaceutical Co., Inc. | Methods and compositions for inhibition or irritation by disaccharide and metal ions |
FR2863498A1 (en) * | 2003-12-12 | 2005-06-17 | Rocher Yves Biolog Vegetale | Use of gum arabic as an active agent in cosmetic and dermatological compositions, useful particularly for treatment and prevention of ageing of the skin |
FR2863887A1 (en) * | 2003-12-23 | 2005-06-24 | Jean Noel Thorel | Well tolerated, biocompatible dermatological and/or cosmetic galenic base, having aqueous phase containing polyols, e.g. sugars and/or sugar alcohols, and preferably lipid phase containing lipo-regulator |
FR2883473A1 (en) * | 2005-03-25 | 2006-09-29 | Biolog Vegetale Yves Rocher Sa | Topical cosmetic composition, useful to induce the tanning of the skin, to fight against cutaneous aging and to protect skin from UV rays, comprises an extract of chicle gum and a vehicle |
FR2883750A1 (en) * | 2005-04-04 | 2006-10-06 | Virbac Sa Sa | TOPICAL COMPOSITIONS AND USES THEREOF |
EP2073787A2 (en) * | 2006-10-05 | 2009-07-01 | Société Industrielle Limousine d'Application Biologique Dite SILAB | Use of an active ingredient derived from flax that acts on the papillary dermis, for its anti-ageing action |
USRE41278E1 (en) | 1999-01-08 | 2010-04-27 | Yu Ruey J | N-acetyl aldosamines and related N-acetyl compounds, and their topical use |
FR2940610A1 (en) * | 2008-12-30 | 2010-07-02 | Oreal | ASSOCIATION OF MONOSACCHARIDES WITH C-GLYCOSIDE DERIVATIVES AND ITS USE IN COSMETICS |
EP2204162A1 (en) * | 2008-12-30 | 2010-07-07 | L'oreal | Use of monosaccharides and composition |
US9421157B2 (en) | 2006-07-03 | 2016-08-23 | L'oreal | Use of C-glycoside derivatives as pro-desquamating active agents |
-
1988
- 1988-02-23 FR FR8802162A patent/FR2609397B1/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
"THE MERCK INDEX - AN ENCYCLOPEDIA OF CHEMICALS, DRUGS, AND BIOLOGICALS", 1983, édition 10, pages 314,315,384,609,1195,1196,1449, Merck & Co., Inc., Rahway, N.J., US * |
Cited By (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2639828A1 (en) * | 1988-12-01 | 1990-06-08 | Lvmh Rech | USE OF KAEMPFEROL AND SOME DERIVATIVES THEREOF FOR THE PREPARATION OF A COSMETIC OR PHARMACEUTICAL COMPOSITION |
WO1990006104A1 (en) * | 1988-12-01 | 1990-06-14 | Lvmh Recherche | Use of kaempferol and certain derivatives thereof for the preparation of a cosmetic or pharmaceutical composition |
EP0382210A1 (en) * | 1989-02-08 | 1990-08-16 | Unitika Ltd. | The use of deacetylated chitin for preparing a medicament for the treatment of inflammatory skin diseases |
WO1990011069A1 (en) * | 1989-03-20 | 1990-10-04 | Parfums Christian Dior | Process for the preparation of a ligand-receptor complex |
FR2645741A1 (en) * | 1989-03-20 | 1990-10-19 | Dior Christian Parfums | METHOD FOR FIXING A PRODUCT ON THE MEMBRANE OF A KERATINOCYTE BY MEANS OF A LIGAND-RECEPTOR BOND, PROCESS FOR PREPARING SUCH A PRODUCT, OBTAINED PRODUCT, COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND PROCESS FOR PREPARING THE SAME |
US5286629A (en) * | 1989-03-20 | 1994-02-15 | Parfums Christian Dior | Method of binding a product to the membrane of a keratinocyte by means of a ligand-receptor bond, method of preparing such a product, product obtained, cosmetic or pharmaceutical composition in which it is present and its method of preparation |
FR2652742A1 (en) * | 1989-10-11 | 1991-04-12 | Vacher Dominique | Anallergic cosmetic and dermopharmaceutical compositions |
EP0500718A4 (en) * | 1989-11-09 | 1994-09-14 | Byron A Donzis | Insoluble yeast extract |
EP0500718A1 (en) * | 1989-11-09 | 1992-09-02 | Byron A Donzis | Insoluble yeast extract. |
EP0432309A1 (en) * | 1989-12-15 | 1991-06-19 | Laevosan-Gesellschaft m.b.H. | Sugar derivatives, process for their preparation and their use |
WO1992015311A1 (en) * | 1991-03-01 | 1992-09-17 | Depha Team S.R.L. | Dietetic or pharmaceutical compositions for the restoration of adenine nucleotide cell content in skeletal and cardiac muscles |
FR2683721A1 (en) * | 1991-11-15 | 1993-05-21 | Inocosm Laboratoires | POLAR LIPID COMPOSITION FOR VEHICULATING AN ACTIVE AGENT AND / OR PENETRATING IT INTO A TARGET CELL |
WO1994002586A2 (en) * | 1992-07-24 | 1994-02-03 | Agricultural And Food Research Council | Repression of virulent gene expression |
WO1994002586A3 (en) * | 1992-07-24 | 1994-03-17 | Agricultural & Food Res | Repression of virulent gene expression |
EP0693928A4 (en) * | 1993-03-31 | 1998-06-03 | Nutramax Lab Inc | Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
US6492349B1 (en) | 1993-03-31 | 2002-12-10 | Nutramax Laboratories, Inc. | Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
US5910490A (en) * | 1993-08-17 | 1999-06-08 | Roc. S.A. | Use of oligosaccharides in the prevention and treatment of the aging of tissues |
WO1995005155A1 (en) * | 1993-08-17 | 1995-02-23 | Roc S.A. | Use of oligosaccharides for the prevention and treatment of tissue ageing |
FR2709061A1 (en) * | 1993-08-17 | 1995-02-24 | Robert Ladislas | Use of oligosaccharides in the prevention and treatment of tissue aging. |
WO1996023479A3 (en) * | 1995-02-03 | 1997-03-06 | Beiersdorf Ag | Anti-adhesive active principles |
WO1996023479A2 (en) * | 1995-02-03 | 1996-08-08 | Beiersdorf Ag | Anti-adhesive active principles |
WO1996025142A1 (en) * | 1995-02-15 | 1996-08-22 | Parfums Christian Dior | Use of galactosylglycerides and of naturally occurring extracts containing such products in cosmetics, pharmaceutics and particularly dermatology |
FR2730409A1 (en) * | 1995-02-15 | 1996-08-14 | Dior Christian Parfums | USE OF GALACTOLIPIDS, IN PARTICULAR GALACTOSYLGLYCERIDES, AND EXTRACTS OF NATURAL ORIGIN CONTAINING THESE PRODUCTS, IN THE COSMETIC, PHARMACEUTICAL AND IN PARTICULAR DERMATOLOGICAL FIELDS |
FR2743296A1 (en) * | 1996-01-10 | 1997-07-11 | Oreal | New cleansing or make-up removal composition |
EP0783883A3 (en) * | 1996-01-10 | 1997-08-13 | L'oreal | Use of polyholosides in cleaning compositions or in make-up removers, and compositions containing the same |
EP0852946A3 (en) * | 1996-11-29 | 1998-09-16 | Gianfranco De Paoli Ambrosi | Composition for cosmetic, pharmaceutical or dietetic use based on an amino-sugar and/or a polyhydroxylic acid |
US6583123B2 (en) | 1996-12-23 | 2003-06-24 | Nutramax Laboratories, Inc. | Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue |
US6255295B1 (en) | 1996-12-23 | 2001-07-03 | Nutramax Laboratories, Inc. | Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue |
US6271213B1 (en) | 1996-12-23 | 2001-08-07 | Nutramax Laboratories, Inc. | Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue |
EP0979090A1 (en) * | 1997-04-28 | 2000-02-16 | Nutramax Laboratories, Inc. | Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine |
EP1849471A1 (en) * | 1997-04-28 | 2007-10-31 | Nutramax Laboratories, Inc. | Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and S-adenosylmethionine |
EP0979090A4 (en) * | 1997-04-28 | 2000-10-18 | Nutramax Lab Inc | Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine |
USRE42902E1 (en) | 1999-01-08 | 2011-11-08 | Tristrata, Inc. | N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use |
USRE41339E1 (en) | 1999-01-08 | 2010-05-18 | Tristrata, Inc. | N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use |
USRE44302E1 (en) | 1999-01-08 | 2013-06-18 | Ruey J. Yu | N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use |
USRE41278E1 (en) | 1999-01-08 | 2010-04-27 | Yu Ruey J | N-acetyl aldosamines and related N-acetyl compounds, and their topical use |
US6706696B1 (en) | 1999-03-12 | 2004-03-16 | Biotec Asa | Cosmetic and/or pharmaceutical preparations |
WO2000054743A1 (en) * | 1999-03-12 | 2000-09-21 | Biotec Asa | Cosmetic and/or pharmaceutical preparations |
EP1075836A2 (en) * | 1999-08-09 | 2001-02-14 | Yaizu Suisankagaku Industry Co., Ltd. | Skin care of food composition containing N-acetyl-glucosamine |
EP1075836A3 (en) * | 1999-08-09 | 2001-04-25 | Yaizu Suisankagaku Industry Co., Ltd. | Skin care of food composition containing N-acetyl-glucosamine |
WO2002076423A2 (en) * | 2001-03-22 | 2002-10-03 | The Procter & Gamble Company | Skin care compositions containing a sugar amine |
WO2002076423A3 (en) * | 2001-03-22 | 2003-03-13 | Procter & Gamble | Skin care compositions containing a sugar amine |
DE10126396A1 (en) * | 2001-05-31 | 2002-12-05 | Beiersdorf Ag | Cosmetic or dermatological preparations containing glucosamine, useful e.g. for treatment, care and prophylaxis of sensitive skin and treatment of inflammatory conditions such as eczema or psoriasis |
WO2003092703A1 (en) * | 2002-04-30 | 2003-11-13 | Hisamitsu Pharmaceutical Co., Inc. | Methods and compositions for inhibition or irritation by disaccharide and metal ions |
FR2863498A1 (en) * | 2003-12-12 | 2005-06-17 | Rocher Yves Biolog Vegetale | Use of gum arabic as an active agent in cosmetic and dermatological compositions, useful particularly for treatment and prevention of ageing of the skin |
FR2863887A1 (en) * | 2003-12-23 | 2005-06-24 | Jean Noel Thorel | Well tolerated, biocompatible dermatological and/or cosmetic galenic base, having aqueous phase containing polyols, e.g. sugars and/or sugar alcohols, and preferably lipid phase containing lipo-regulator |
FR2883473A1 (en) * | 2005-03-25 | 2006-09-29 | Biolog Vegetale Yves Rocher Sa | Topical cosmetic composition, useful to induce the tanning of the skin, to fight against cutaneous aging and to protect skin from UV rays, comprises an extract of chicle gum and a vehicle |
WO2006106220A3 (en) * | 2005-04-04 | 2007-01-04 | Virbac Sa | Topical compositions comprising several mono- and/or oligosaccharides for treating skin diseases of warm blood hair coated animals. |
WO2006106220A2 (en) * | 2005-04-04 | 2006-10-12 | Virbac Sa | Topical compositions comprising several mono- and/or oligosaccharides for treating skin diseases of warm blood hair coated animals. |
FR2883750A1 (en) * | 2005-04-04 | 2006-10-06 | Virbac Sa Sa | TOPICAL COMPOSITIONS AND USES THEREOF |
AU2006231248B2 (en) * | 2005-04-04 | 2012-08-02 | Virbac Sa | Topical compositions comprising several mono- and/or oligosaccharides for treating skin diseases of warm blood hair coated animals. |
US9421157B2 (en) | 2006-07-03 | 2016-08-23 | L'oreal | Use of C-glycoside derivatives as pro-desquamating active agents |
EP2073787A2 (en) * | 2006-10-05 | 2009-07-01 | Société Industrielle Limousine d'Application Biologique Dite SILAB | Use of an active ingredient derived from flax that acts on the papillary dermis, for its anti-ageing action |
EP3744311A1 (en) * | 2006-10-05 | 2020-12-02 | Société Industrielle Limousine d'Application Biologique Dite SILAB | Use of an active ingredient from flax acting on the papillary dermis, for anti-ageing action |
FR2940610A1 (en) * | 2008-12-30 | 2010-07-02 | Oreal | ASSOCIATION OF MONOSACCHARIDES WITH C-GLYCOSIDE DERIVATIVES AND ITS USE IN COSMETICS |
US8445459B2 (en) | 2008-12-30 | 2013-05-21 | L'oreal | Combination of monosaccharide with C-glycoside derivative and use thereof |
US9364411B2 (en) | 2008-12-30 | 2016-06-14 | L'oreal | Use of monosaccharides and composition therefor |
EP2206491A1 (en) * | 2008-12-30 | 2010-07-14 | L'oreal | Association of monosaccharides and C-glycoside derivatives and its use in cosmetics |
EP2204162A1 (en) * | 2008-12-30 | 2010-07-07 | L'oreal | Use of monosaccharides and composition |
Also Published As
Publication number | Publication date |
---|---|
FR2609397B1 (en) | 1991-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2609397A1 (en) | Use of a substance or composition of carbohydrate nature as active principle of a dermatological and/or cosmetological and/or pharmaceutical and/or cell-stimulating composition, and composition containing such a substance or composition of carbohydrate nature | |
CH661205A5 (en) | COSMETIC OR DERMATOLOGICAL COMPOSITIONS FOR SKIN CARE. | |
ES2209197T3 (en) | USE OF GINSENOSIDE RB1 TO STIMULATE THE SYNTHESIS OF ELASTINE. | |
EP2882415A2 (en) | Cosmetic or pharmaceutical moisturising ingredient | |
JP2003526646A (en) | Use of plant extracts and sugars to protect keratinous tissue | |
US11007136B2 (en) | Cosmetic composition for wrinkle reduction containing gypenoside isolated from Gynostemma pentaphyllum | |
WO1992009262A1 (en) | Use of medicago saponins for the preparation of cosmetic or pharmaceutical compositions, dermatological compositions in particular, helping renew the epidermis, stimulating regrowth of hair, or delaying hair loss | |
CN100525741C (en) | Novel formulation of biocompatible galenic matrices | |
KR102207561B1 (en) | Natural cosmetic composition containing glycine soja(soybeen) seed extract | |
WO1997006659A2 (en) | Use of an eriobotrya japonica extract | |
KR100338327B1 (en) | External application for enhancing the skin permeability of the active components therein | |
FR2639828A1 (en) | USE OF KAEMPFEROL AND SOME DERIVATIVES THEREOF FOR THE PREPARATION OF A COSMETIC OR PHARMACEUTICAL COMPOSITION | |
FR3110420A1 (en) | PLANT COMPLEX BASED ON BETULINIC ACID AND AN AQUEOUS CHAGA EXTRACT AND APPLICATIONS IN COSMETICS | |
EP1530480B1 (en) | Cosmetic composition comprising monosaccharides or polysaccharides, uses and treatment methods | |
SK106599A3 (en) | Skin care product | |
FR3095345A1 (en) | COSMETIC COMPOSITION INCLUDING A POLYMERIC MATRIX | |
EP2874596B1 (en) | Extract of cotton fibres and cosmetic composition and use thereof for protecting, nourishing and hydrating the skin | |
EP1631594A1 (en) | Novel agent for stimulating the release of beta-endorphins, cosmetic and/or dermatological compositions containing same and uses thereof | |
JP2003335619A (en) | Skin care preparation for external use | |
FR2735981A1 (en) | COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING A PLANT EXTRACT OF GENUS FOETIDIA | |
JP2003335622A (en) | Skin care preparation for external use | |
EP2229145B1 (en) | Use of a poppy petal extract for skin nutrition | |
EP0835121A1 (en) | COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING AN EXTRACT OF PLANTS OF GENUS $i(FILICIUM), AND USE OF SAID EXTRACT FOR STIMULATING GLYCOSAMINOGLYCAN SYNTHESIS | |
FR2574661A1 (en) | New skin care compositions containing Oenothera oil and spleen tissue extracts | |
ES2393087T3 (en) | Use of a cotton honeydew extract as an active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |